Farms.com Home   News

Factors to Consider Before Using a Soybean Seed Treatment

By Kiersten Wise and Mandy Bish et.al

There are many seed treatments available to manage soybean pests, but most are only effective during the first few weeks after planting. In addition, there are many products and product combinations available, which can make it difficult to understand which treatments consistently provide a positive return on investment.

This publication describes the factors to consider when making soybean seed treatment decisions. This publication discusses three major types of seed treatments: fungicides, insecticides, and nematicides.

Fungicide Seed Treatments

Fungicide seed treatments can provide protection against two different types of pathogens: seedborne fungal pathogens (e.g., the Phomopsis seed decay fungus) and soilborne pathogens that infect seedlings and roots (e.g., Pythophthora spp., the sudden death syndrome (SDS) fungus, etc.). If you are considering a fungicide seed treatment, then it’s important to know that they are more likely to provide a benefit when:

  • Fields that have a history of soybean seedling diseases, SDS, and/or red crown rot

  • Planting into soils below 60°F (16°C)

  • Planting into compacted soils

  • Seeding  rates less than 140,000 seeds per acre

  • Planting in no-till or reduced tillage systems, or fields with high levels of surface residue, such as cover crops

  • Fields that have a history of flooded soils

  • Seeds that have high levels of seedborne fungal infestation

  • Fields that are in continuous (two or more years) soybean

  • Varieties that are susceptible to diseases such as Phytophthora root and stem rot and SDS are planted

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.